Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
The IDF - Direct Relief Global Diabetes Partnership builds on the organizations' joint efforts to encourage manufacturers to donate type 2 diabetes-related medical devices...